http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004034411-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b91a06ee3b97b163b6fd5cac22a16479
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_387827a27841b2e92e78e089ebf7307e
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/H01F1-36
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-1251
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/H01F1-0054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y25-00
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/H01F1-36
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/H01F1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-12
filingDate 2002-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_615972b99434b649865814d36d5f9105
publicationDate 2004-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2004034411-A1
titleOfInvention Stabilized superparamagnetic particles
abstract The invention relates to stabilized superparamagnetic particles which consist of superparamagnetic single domain particles and aggregations of superparamagnetic particles which are stabilized with aliphatic dicarboxylic or polycarboxylic acids and which contain charged ions of chemical elements on the surface of the small superparamagnetic single-domain particles and, optionally, an additional tissue binding substance or pharmacologically effective substance. The superparamagnetic particles consist of a mixture of small superparamagnetic single domain particles have a particle size ranging from 3 to 5 namometers and stable, degradable aggregations of small superparamagnetic particles having a particle size of 10-1000 nanometers, and are made of iron hydroxide, iron oxide hydrate, iron oxide, iron mixed oxide or iron. The novel particles can be used as bacteriostatics and radio pharmaceuticals harming tumors, in order to prevent restenosis, in order to combat inflammatory diseases, for the functional control of organs, for magnetic drug targeting, as MR contrasting agents, as magnetic ion exchangers and magnetic adsorbients for separation methods, in the production of extremely small metal particles, as magnetic particles for in vitro diagnosis, optionally in conjunction with magnetic fields.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021175528-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007065935-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102005059751-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3875185-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-112006004066-B4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006261610-A
priorityDate 2002-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0772776-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5928958-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0888545-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226447063
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226447062
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444020
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394721
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414493
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4911
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395793
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19990
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11535903
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135812317
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8567
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87063904
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87063903
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397450
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226447064

Total number of triples: 41.